The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The gene symbol “AAF47782” is ambiguous as a biological name, and literature is limited for this specific protein. In this record, AAF47782 is best treated as a submitted sequence/accession-derived name for the D. melanogaster gene CG10359 (FlyBase gene FBgn0035452), not as a widely used functional gene symbol. The target is UniProt B7Z0B2, described as a fibrinogen C-terminal domain-containing protein. Exact-identifier searches did not reveal evidence that the literature discussed below concerns a different organism or an unrelated same-symbol gene.
The most defensible annotation is therefore: CG10359 encodes a poorly characterized, likely extracellular fibrinogen-related protein, possibly belonging to an angiopoietin-like structural class, whose biochemical ligand/receptor relationships and physiological function remain unknown. It has no demonstrated catalytic reaction or transporter substrate. Available experiments show regulation or detection in several contexts—irradiation/apoptosis, altered EGFR signaling, Mediator-module perturbation, and tissue secretomes—but do not establish a definitive signaling pathway or phenotype.
| Topic | Finding | Evidence type | Confidence | Key limitation |
|---|---|---|---|---|
| Identity and domain architecture | Target is Drosophila melanogaster CG10359 (aliases AAF47782 and FBpp0072995), represented by UniProt B7Z0B2 and annotated as a fibrinogen C-terminal domain-containing protein with Fibrinogen-like_C/Fibrinogen_C domain signatures. | UniProt and InterPro/Pfam sequence-based annotation supplied with the query | High for identity; moderate for domain assignment | The submitted name “AAF47782” is not a conventional functional gene symbol; domain presence does not establish ligand, receptor, or biochemical activity. |
| Radiation-responsive expression | CG10359 mRNA was induced approximately 2 hours after irradiation; induction was absent or reduced/delayed in a p53 mutant context in which radiation-induced caspase activation and apoptosis were impaired. | Gene-specific transcript analysis in irradiated Drosophila wing imaginal discs (bilak2014dyingcellsprotect pages 8-8) | Moderate | Establishes an apoptosis/radiation-associated transcriptional response, not direct regulation by p53 or a functional role for the protein. |
| Radiation-survival phenotype | A chromosomal deficiency deleting CG10359 gave a reported negative result in the tested protection-from-cell-death assay. | Genetic deletion/deficiency test; negative result not shown (bilak2014dyingcellsprotect pages 8-8) | Low–moderate | The deficiency may remove additional genes, and an unpublished negative result cannot exclude redundancy, context-specific activity, or incomplete assay sensitivity. |
| Tie/Angiopoietin hypothesis | CG10359 was described as one of five predicted Drosophila Angiopoietin homologs, but no CG10359–Tie binding, receptor activation, or requirement for Tie-dependent survival was demonstrated. | Homology-based candidate designation plus absence of direct functional evidence (bilak2014dyingcellsprotect pages 8-8) | Low | Structural similarity to an Angiopoietin-like fibrinogen domain is insufficient to assign Tie as its receptor. |
| EGFR-associated expression | CG10359 was listed among genes upregulated under dominant-negative EGFR conditions relative to activated-EGFR wing-disc samples. | Differential-expression screen (butchar2012newnegativefeedback pages 30-34) | Moderate for expression association; low for pathway assignment | No CG10359-specific RNAi phenotype or mechanistic validation was reported; the result does not prove that CG10359 is a direct EGFR target or feedback regulator. |
| Mediator-associated expression | CG10359 appeared among genes changing at least threefold after depletion of one or more Cdk8-module components (Cdk8, CycC, Med12, or Med13) in S2 cells. | High-throughput knockdown expression profiling (kuuluvainen2014cyclindependentkinase8 pages 4-5) | Low–moderate | The available evidence does not specify the responsible knockdown, direction, exact fold change, or directness of regulation. |
| Sex/developmental expression in another fly | In the stalk-eyed fly Teleopsis dalmanni, the CG10359-designated orthology probe was male-biased in larval eye-antennal discs but female-biased in adult heads. | Comparative microarray/orthology-context observation (wilkinson2013sexbiasedgeneexpression pages 3-4) | Moderate for the Teleopsis dataset; very low for inference about D. melanogaster | This is not direct evidence about D. melanogaster CG10359 and provides no molecular-function or localization information. |
| Secretome and tissue origin | A 2025 bioRxiv secretome map detected retained isoform B7Z0B2 in assignments from muscle, heart, wing disc, and neurons, supporting extracellular secretion as a working localization hypothesis. | Tissue-resolved proximity-labeling/proteomic secretome mapping (bosch2026multiomicmappingof pages 36-38) | Moderate, provisional | Non-peer-reviewed preprint; the excerpt provides no CG10359-specific secretion validation, abundance, signal-peptide result, binding partner, destination tissue, or trafficking measurement. |
| Primary molecular function | No enzyme reaction, catalytic substrate, transporter substrate, direct extracellular binding partner, or receptor has been demonstrated for CG10359. | Evidence-gap assessment across the gene-specific studies above (kuuluvainen2014cyclindependentkinase8 pages 4-5, bilak2014dyingcellsprotect pages 8-8, butchar2012newnegativefeedback pages 30-34, bosch2026multiomicmappingof pages 36-38) | High that function remains unestablished | Future biochemical and genetic studies could revise this conclusion. |
| Pathway and phenotype conclusion | No definitive signaling pathway, essential biological process, or reproducible CG10359-specific organismal/cellular phenotype is currently established; radiation/apoptosis, EGFR, and Mediator results are expression associations rather than functional assignments. | Integrated evidence assessment (kuuluvainen2014cyclindependentkinase8 pages 4-5, bilak2014dyingcellsprotect pages 8-8, butchar2012newnegativefeedback pages 30-34) | High | Sparse gene-specific literature and possible redundancy limit negative conclusions. |
Table: Evidence for CG10359/B7Z0B2 supports a predicted fibrinogen-domain, probably secreted protein, but does not yet establish its receptor, biochemical activity, pathway, or phenotype. The table separates direct observations from homology-based and high-throughput inferences.
The supplied identifiers are mutually consistent with a Drosophila melanogaster product: CG10359, Dmel\CG10359, FBpp0072995, AAF47782, and UniProt B7Z0B2. The UniProt record’s predicted fibrinogen-related architecture—InterPro IPR036056, IPR014716, IPR002181 and IPR050373, and Pfam PF00147—is compatible with a literature description of CG10359 as one of five predicted Drosophila angiopoietin homologs. Crucially, that publication did not establish angiopoietin activity, secretion, Tie binding, or receptor activation experimentally (Bilak et al., published 13 March 2014; https://doi.org/10.1371/journal.pgen.1004220). (bilak2014dyingcellsprotect pages 8-8)
The term “fibrinogen C-terminal domain-containing” describes a conserved protein fold rather than a demonstrated fibrinogen/coagulation function. Domain similarity alone cannot determine whether CG10359 is a growth-factor ligand, pattern-recognition protein, extracellular-matrix component, or another type of binding protein. Broader fibrinogen-related-protein functions in other insects or invertebrates should therefore not be transferred to CG10359 without direct evidence.
No purified-protein biochemical study, binding assay, receptor-activation assay, structural study, or substrate-specificity experiment was found for CG10359. Accordingly:
Thus, assigning CG10359 as a Tie ligand, an innate-immune pattern-recognition receptor, or a matrix protein would currently be overannotation.
The strongest localization evidence is recent but provisional. A tissue-resolved Drosophila secretome study retained isoform B7Z0B2 in secretome assignments originating from muscle, heart, wing disc, and neurons. The map used empirical false-discovery thresholds based on secreted/receptor controls and intracellular negative controls, supporting extracellular secretion as a working model. However, the retrieved evidence gives no CG10359-specific signal-peptide result, abundance, independent secretion validation, destination tissue, or trafficking measurement. The work was posted as a bioRxiv preprint on 11 July 2025 and was not peer reviewed (Bosch et al.; https://doi.org/10.1101/2025.07.09.659702). (bosch2026multiomicmappingof pages 36-38)
Consequently, extracellular/secreted is the best current localization hypothesis, but it should be labeled provisional rather than experimentally definitive. There is no evidence that the mature protein functions in the nucleus, cytosol, or a specific organelle.
In irradiated wing imaginal discs, CG10359 mRNA was induced approximately 2 hours after irradiation, alongside Pvf1 and Pvf2. This induction was lost in a p53 mutant background in which radiation-induced caspase activation and apoptosis were reduced or delayed. The result places CG10359 transcription in an irradiation/apoptosis-associated response, but it does not distinguish direct p53 transcriptional control from an indirect consequence of dying cells (Bilak et al., 13 March 2014; https://doi.org/10.1371/journal.pgen.1004220). (bilak2014dyingcellsprotect pages 8-8)
The same study’s functional evidence was negative: a chromosomal deficiency deleting CG10359 did not alter the tested protection produced by induced cell death. That negative result was not shown in detail and cannot exclude redundancy or another context-specific function, but it means CG10359 was not demonstrated to be required for Tie-dependent radiation protection. The study therefore supports CG10359 as a response-associated candidate, not as an established survival signal. (bilak2014dyingcellsprotect pages 8-8)
CG10359 was listed among transcripts upregulated in dominant-negative EGFR conditions relative to activated-EGFR wing-disc samples. This suggests that its transcription responds to EGFR pathway state, potentially inversely to pathway activity. No CG10359-specific RNAi phenotype or mechanistic validation was reported, however, so the result does not establish CG10359 as a direct EGFR target or negative-feedback regulator (Butchar et al., published August 2012; https://doi.org/10.1534/genetics.112.141093). (butchar2012newnegativefeedback pages 30-34)
CG10359 appeared in a heat map of genes changing by at least threefold after depletion of Cdk8, CycC, Med12, or Med13 in S2 cells. The available passage does not identify which perturbation affected CG10359, the direction or exact magnitude of change, or whether regulation was direct. It therefore provides evidence of transcriptional sensitivity to one or more Mediator-module perturbations, but no specific molecular pathway assignment (Kuuluvainen et al., published 6 June 2014; https://doi.org/10.1074/jbc.M113.541904). (kuuluvainen2014cyclindependentkinase8 pages 4-5)
Although that study concerned Serpent-dependent innate-immunity genes, CG10359’s appearance in its profiling data is insufficient to annotate CG10359 itself as an immune effector or pattern-recognition molecule.
A stalk-eyed-fly study reported that a CG10359-designated orthology probe was male-biased in larval eye-antennal discs but female-biased in adult heads. The broader experiment assayed 3,748 genes, of which 985 were sex-biased in larval eye discs and 242 in adult heads. This observation concerns Teleopsis dalmanni, not direct measurement of D. melanogaster CG10359, and cannot establish its fly localization or function (Wilkinson et al., published 21 March 2013; https://doi.org/10.1371/journal.pone.0059826). (wilkinson2013sexbiasedgeneexpression pages 3-4)
No 2023–2024 publication retrieved by exact searches for CG10359, B7Z0B2, or AAF47782 provided direct molecular or genetic characterization of this protein. This is an important negative finding: there is no recent authoritative basis for upgrading CG10359 to a defined ligand, enzyme, immune receptor, or pathway component. The newest gene-specific evidence located was the 2025 secretome preprint, which advances localization by detecting B7Z0B2 in multiple tissue-origin secretomes but does not resolve mechanism. (bosch2026multiomicmappingof pages 36-38)
No clinical, agricultural, diagnostic, or biotechnology application specific to CG10359 was identified. Its present value is principally as:
These are research opportunities, not validated implementations.
A conservative database annotation would be:
Predicted secreted fibrinogen C-terminal domain-containing protein; molecular function and physiological role unknown. CG10359 transcript responds to irradiation/apoptosis and to perturbations of EGFR and Mediator-module activity; evidence does not establish direct pathway membership, Tie-receptor engagement, or a required survival phenotype.
The highest-value experiments would be: endogenous epitope tagging to verify secretion and tissue source; a clean CRISPR null with rescue; purified-protein interactome or receptor-binding screens; Tie phosphorylation/activation assays; spatial expression after irradiation; and infection assays only if expression or binding data first support an immune role.
References
(bilak2014dyingcellsprotect pages 8-8): Amber Bilak, Lyle Uyetake, and Tin Tin Su. Dying cells protect survivors from radiation-induced cell death in drosophila. Mar 2014. URL: https://doi.org/10.1371/journal.pgen.1004220, doi:10.1371/journal.pgen.1004220. This article has 59 citations and is from a domain leading peer-reviewed journal.
(butchar2012newnegativefeedback pages 30-34): Jonathan P Butchar, Donna Cain, Sathiya N Manivannan, Andrea D McCue, Liana Bonanno, Sarah Halula, Sharon Truesdell, Christina L Austin, Thomas L Jacobsen, and Amanda Simcox. New negative feedback regulators of egfr signaling in drosophila. Genetics, 191:1213-1226, Aug 2012. URL: https://doi.org/10.1534/genetics.112.141093, doi:10.1534/genetics.112.141093. This article has 35 citations and is from a domain leading peer-reviewed journal.
(kuuluvainen2014cyclindependentkinase8 pages 4-5): Emilia Kuuluvainen, Heini Hakala, Essi Havula, Michelle Sahal Estimé, Mika Rämet, Ville Hietakangas, and Tomi P. Mäkelä. Cyclin-dependent kinase 8 module expression profiling reveals requirement of mediator subunits 12 and 13 for transcription of serpent-dependent innate immunity genes in drosophila. Jun 2014. URL: https://doi.org/10.1074/jbc.m113.541904, doi:10.1074/jbc.m113.541904. This article has 28 citations and is from a domain leading peer-reviewed journal.
(wilkinson2013sexbiasedgeneexpression pages 3-4): Gerald S. Wilkinson, Philip M. Johns, Jackie D. Metheny, and Richard H. Baker. Sex-biased gene expression during head development in a sexually dimorphic stalk-eyed fly. PLoS ONE, 8:e59826, Mar 2013. URL: https://doi.org/10.1371/journal.pone.0059826, doi:10.1371/journal.pone.0059826. This article has 30 citations and is from a peer-reviewed journal.
(bosch2026multiomicmappingof pages 36-38): Justin A. Bosch, Pierre Michel Jean Beltran, Cooper Cavers, James Thai LaGraff, Randy Melanson, Ankita Singh, Weihang Chen, Yanhui Hu, Sudhir Gopal Tattikota, Ying Liu, Yousuf Hashmi, John M. Asara, Tess Branon, Alice Y. Ting, Steven A. Carr, and Norbert Perrimon. Multi-omic mapping of drosophila protein secretomes reveals tissue-specific origins and inter-organ trafficking. bioRxiv, Jul 2026. URL: https://doi.org/10.1101/2025.07.09.659702, doi:10.1101/2025.07.09.659702. This article has 4 citations.